On March 11^th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Director in the Field of Pharmacology (Approval Notice).

General Field: Pharmacology

Position at the Time of Case Filing: Senior Director

Country of Origin: India

State of Residence at the Time of Filing: New Jersey

Approval Notice Date: March 11^th, 2021

Processing Time: 12 months

Case Summary:

With an M.D. in clinical pharmacology and an M.B.B.S., a senior director engaged us to file an EB-1A petition, which is a request for an employment-based immigrant visa in the classification as an alien of extraordinary ability in the field of pharmacology. Thus, we began evaluating his extensive background of expertise, and we countersigned the retainer agreement, thereby extending the reasonable expectation that he can continue advancing in the intended field in the United States.

We incorporated the following details in our client’s EB1A petition:

• We noted the 38 times his work was cited, demonstrating that these publications are widely recognized and relied upon by independent scholars and all of his recommenders are internationally renowned experts in the field of pharmacology, belonging to prestigious institutions.
• Additionally, we confirmed that our client judged the work of others 30 times. Only superiors in their field are invited to perform this important review work, signifying his important standing in the field.
• We also highlighted the 6 peer-reviewed scientific articles and 3 patent applications he published. His work has been published in some of the most prestigious, high impact journals in his field. Moreover, these papers have been published in the top journals in his field, reflecting his peers’ recognition of the value of this research.
• On top of all, we stipulated his research focused on treating dermatological disorders. His research definitely addresses some of our nation’s most pressing issues in understanding the causes and treatments for dermatological disease.
• To strengthen his case, we included recommendation letters signed by five other well-acknowledged researchers in the field, and one of them worded,

“Through this work, [our client] has established excellent new treatments for patients suffering from psoriasis that have reduced the side effects associated with their treatment. His work has therefore benefitted a significant portion of the American population suffering from this condition, and I am confident that his continued presence and work in the United States will produce significant benefits to patients suffering from the dermatological disease.”

Our client received the EB-1A petition approval without any request for evidence (RFE) and within 10 days as he upgraded his regular service to the premium processing service. Thanks to our team’s persistent follow-up, he could finally obtain his EB1A approval. We congratulate him on getting closer to achieving green card success. Our team would like to thank him for choosing our law firm to be a part of this journey.